Cintas Corporation (CTAS) has been under the scanner of various investment entities. Federated Hermes Inc., Bank of New York Mellon Corp, New York State Common Retirement Fund, Mitsubishi UFJ Trust & Banking Corp, and Vest Financial LLC have lowered their holdings in CTAS. Conversely, AustralianSuper Pty Ltd, Y Intercept Hong Kong Ltd, and a number of other firms including Mirae Asset Global Investments Co. Ltd., Allstate Corp, UniSuper Management Pty Ltd, and Scalar Gauge Management LLC have enlarged their stakes. Wells Fargo has upgraded CTAS and designated it as a top pick for 2026. Conversely, Citi has retained its sell rating despite raising its target for the company. The bio-tech company marked the announcement of a $0.45 quarterly dividend. In the Q1 2026 and Q4 2025 earnings calls, CTAS indicated strong revenue growth and an optimistic outlook. CTAS has made it to the Forbes 2026 America’s Best-in-State Companies List, while it continues to receive mixed coverage by analysts.
Cintas Corp CTAS News Analytics from Wed, 14 May 2025 07:00:00 GMT to Sat, 31 Jan 2026 09:35:13 GMT - Innovation -1 - Rumor 0
